货号:A160831
同义名:
AG 337; Thymitaq
Nolatrexed 2HCl 是一种胸苷酸合成酶抑制剂,作为水溶性喹唑啉类叶酸类似物,竞争性占据胸苷酸合成酶(TS)的叶酸结合位点,抑制胸苷酸合成,阻断DNA复制。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| Concentration | Treated Time | Description | References | |
| L1210 cells | 1 µM | 16 hours | Evaluate the potentiation of 5-FU cytotoxicity by NU3076 and dipyridamole. Results showed significant potentiation at high concentrations of 5-FU (30 µM and 100 µM). | Br J Cancer. 1999 Aug;80(11):1738-46 |
| L1210 cells | 10 µM | 16 hours | Evaluate the potentiation of nolatrexed cytotoxicity by NU3076 and dipyridamole. Results showed that 1 µM NU3076 and 1 µM dipyridamole significantly reduced the LC90 by > threefold. | Br J Cancer. 1999 Aug;80(11):1738-46 |
| WiDr B | 2.70 µM | 72 hours | To evaluate the anti-proliferative effects of Nolatrexed on WiDr B cells, IC50 value was 2.70 µM | Br J Cancer. 2007 Mar 12;96(5):769-75 |
| WiDr T | 2.30 µM | 72 hours | To evaluate the anti-proliferative effects of Nolatrexed on WiDr T cells, IC50 value was 2.30 µM | Br J Cancer. 2007 Mar 12;96(5):769-75 |
| Lovo li | 2.10 µM | 72 hours | To evaluate the anti-proliferative effects of Nolatrexed on Lovo li cells, IC50 value was 2.10 µM, showing higher sensitivity compared to Lovo 92 cells | Br J Cancer. 2007 Mar 12;96(5):769-75 |
| Lovo 175X2 | 19.00 µM | 72 hours | To evaluate the anti-proliferative effects of Nolatrexed on Lovo 175X2 cells, IC50 value was 19.00 µM, showing 3-fold resistance compared to Lovo 92 cells | Br J Cancer. 2007 Mar 12;96(5):769-75 |
| Lovo 92 | 5.15 µM | 72 hours | To evaluate the anti-proliferative effects of Nolatrexed on Lovo 92 cells, IC50 value was 5.15 µM | Br J Cancer. 2007 Mar 12;96(5):769-75 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.80mL 0.56mL 0.28mL |
14.00mL 2.80mL 1.40mL |
27.99mL 5.60mL 2.80mL |
|
| CAS号 | 152946-68-4 |
| 分子式 | C14H14Cl2N4OS |
| 分子量 | 357.26 |
| SMILES Code | O=C1N=C(N)NC2=C1C(SC3=CC=NC=C3)=C(C)C=C2.[H]Cl.[H]Cl |
| MDL No. | MFCD00917041 |
| 别名 | AG 337; Thymitaq; Nolatrexed (hydrochloride); Nolatrexed dihydrochloride |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, 2-8°C |
| 溶解方案 |
DMSO: 40 mg/mL(111.96 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 50 mg/mL(139.95 mM),配合低频超声助溶 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1